Evidence map›Paper›PMID 33686768›Full record

ArticleTransboundary and emerging diseases2022

Serological evidence of SARS-CoV-2 and co-infections in stray cats in Spain.

Sergio Villanueva-Saz, Jacobo Giner, Ana Pilar Tobajas, María Dolores Pérez, Andrés Manuel González-Ramírez, Javier Macías-León, Ana González, Maite Verde, Andrés Yzuel, Ramón Hurtado-Guerrero and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Transboundary and emerging diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Exposure of Wild Ruminants toVeterinary sciences · 2025
    Article
  5. Article
  6. Seroprevalence ofPathogens (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Assessing the Potential Role of Cats (Pathogens (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Sergio Villanueva-SazClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, Zaragoza, Spain.ORCID https://orcid.org/0000-0001-6209-4282
Jacobo GinerClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, Zaragoza, Spain.
Ana Pilar TobajasInstituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), Zaragoza, Spain.
María Dolores PérezInstituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), Zaragoza, Spain.
Andrés Manuel González-RamírezInstitute for Biocomputation and Physics of Complex Systems (BIFI), Edificio I+D, Campus Rio Ebro, University of Zaragoza, Zaragoza, Spain.
Javier Macías-LeónInstituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), Zaragoza, Spain.
Ana GonzálezDeparment of Animal Pathology, Veterinary Faculty, University of Zaragoza, Zaragoza, Spain.
Maite VerdeClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, Zaragoza, Spain.
Andrés YzuelClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, Zaragoza, Spain.
Ramón Hurtado-GuerreroInstitute for Biocomputation and Physics of Complex Systems (BIFI), Edificio I+D, Campus Rio Ebro, University of Zaragoza, Zaragoza, Spain.
Julián PardoAragon I+D Foundation (ARAID), Zaragoza, Spain.
Llipsy SantiagoAragon Health Research Institute (IIS Aragón), Zaragoza, Spain.
José Ramón Paño-PardoAragon Health Research Institute (IIS Aragón), Zaragoza, Spain.
Héctor RuízDeparment of Animal Pathology, Veterinary Faculty, University of Zaragoza, Zaragoza, Spain.
Delia María LacastaInstituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), Zaragoza, Spain.ORCID https://orcid.org/0000-0002-7822-6646
Lourdes SánchezInstituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), Zaragoza, Spain.
Diana MartelesClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, Zaragoza, Spain.
Ana Pilar GraciaInstituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), Zaragoza, Spain.
Antonio FernándezClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, Zaragoza, Spain.
Universidad de Zaragoza · ESHospital Clínico Universitario Lozano Blesa · ESInstituto de Investigación Sanitaria Aragón · ESUniversity of Copenhagen · DK

Funding

Agencia Estatal de Investigación SAF2017-83120-C2-1-RFondo Europeo de Desarrollo Regional, Gobierno de Aragón Group B29_17RGobierno de Aragón E34_R17Gobierno de Aragón LMP58_18MCNU BFU2016-75633-PMCNU CTQ2013-44367-C2-2-PMCNU PID2019-105451GB-I00
6 · The paper itself

Abstract

A new coronavirus known as SARS-CoV-2 emerged in Wuhan in 2019 and spread rapidly to the rest of the world causing the pandemic disease named coronavirus disease of 2019 (COVID-19). Little information is known about the impact this virus can cause upon domestic and stray animals. The potential impact of SARS-CoV-2 has become of great interest in cats due to transmission among domestic cats and the severe phenotypes described recently in a domestic cat. In this context, there is a public health warning that needs to be investigated in relation with the epidemiological role of this virus in stray cats. Consequently, in order to know the impact of the possible transmission chain, blood samples were obtained from 114 stray cats in the city of Zaragoza (Spain) and tested for SARS-CoV-2 and other selected pathogens susceptible to immunosuppression including Toxoplasma gondii, Leishmania infantum, feline leukaemia virus (FeLV) and feline immunodeficiency virus (FIV) from January to October 2020. Four cats (3.51%), based on enzyme-linked immunosorbent assay (ELISA) using the receptor binding domain (RBD) of Spike antigen, were seroreactive to SARS-CoV-2. T. gondii, L. infantum, FeLV and FIV seroprevalence was 12.28%, 16.67%, 4.39% and 19.30%, respectively. Among seropositive cats to SARS-CoV-2, three cats were also seropositive to other pathogens including antibodies detected against T. gondii and FIV (n = 1); T. gondii (n = 1); and FIV and L. infantum (n = 1). The subjects giving positive for SARS-CoV-2 were captured in urban areas of the city in different months: January 2020 (2/4), February 2020 (1/4) and July 2020 (1/4). This study revealed, for the first time, the exposure of stray cats to SARS-CoV-2 in Spain and the existence of concomitant infections with other pathogens including T. gondii, L. infantum and FIV, suggesting that immunosuppressed animals might be especially susceptible to SARS-CoV-2 infection.

Indexed as

Cat DiseasesCoinfectionCOVID-19Immunodeficiency Virus, FelineAnimalsAnimals, WildCatsHumansLeukemia Virus, FelineSARS-CoV-2Seroepidemiologic StudiesSpainconcomitant infectionsCOVID-19ELISASARS-CoV-2serologystray cats

Identifiers

PMID33686768
PMCPMC8250530
OpenAlexW3134716082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.